Charles River Laboratories | CRL - PE Price to Earnings


Charles River Laboratories reported 29.26 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Agilent 20.53 4.51 Mar/2026
Align Technology 22.78 3.05 Mar/2026
Bio-Rad Laboratories 25.28 8.86 Dec/2025
Bruker 36.79 44.56 Mar/2026
Cardinal Health 30.4 5.87 Mar/2026
Charles River Laboratories 29.26 14.31 Mar/2026
Cigna 10.56 0.76 Dec/2025
CVS Health 9.65 4.74 Mar/2026
Danaher 29.29 10.39 Mar/2026
Dentsply International 20.31 9.68 Mar/2026
Elevance Health 17.11 4.71 Jun/2026
Humana 11.07 14.98 Mar/2026
Illumina 32.45 2.07 Mar/2026
Incyte 15.35 0.51 Mar/2026
Intrexon 7.54 221.44 Dec/2021
IQVIA Holdings 19.37 7.21 Mar/2026
Laboratory Of America 25.51 4.65 Mar/2026
Lakefront Biotherapeutics 2.54 0.6 Mar/2026
Lonza 34.34 2.58 Dec/2025
McKesson 23.85 0.07 Dec/2025
Merck 12.74 7.82 Mar/2026
Mettler Toledo International 27.34 5.07 Mar/2026
Novartis 20.17 2.32 Mar/2026
Pfizer 9.32 5.16 Mar/2026
Quest Diagnostics 22.4 2.63 Mar/2026
Revvity 30.79 19.08 Mar/2026
Thermo Fisher Scientific 27.71 3.29 Mar/2026
United Therapeutics 20.42 3.1 Mar/2026
UnitedHealth 20.96 5.68 Jun/2026
Veradigm 11.15 4.63 Sep/2022
Waters 29.75 5.54 Mar/2026
West Pharmaceutical Services 31.99 5.76 Mar/2026